Lumbrokinase Enteric-coated Tablets

Lumbrokinase is a proteolytic enzyme. Animal experiments have shown that this product has the effect of dissolving pulmonary artery thrombus in rabbits and can significantly shorten the time for euglobulin dissolution in rabbits.

The main ingredient of this product is an enzyme complex extracted and separated from artificially cultivated Eisenia fetida.

This product is enteric-coated tablets, which are light yellow to brown in color after removing the enteric coating.

This product is suitable for patients with increased fibrinogen and increased platelet aggregation rate in ischemic cerebrovascular disease.

Oral administration, 2 tablets at a time, 3 times a day, half an hour before meals, or as directed by a doctor.

Some patients experience headache, rash, itchy skin, increased eosinophilia, and gastrointestinal reactions (such as nausea, vomiting, stomach discomfort, increased frequency of loose stools, constipation, etc.).

It is contraindicated for those who are allergic to this product.

Precautions for children: This product has not been tested and there is no reliable reference. Precautions for pregnancy and lactation: This product has not been tested and there is no reliable reference. Precautions for the elderly: This product has not been tested and there is no reliable reference.

This product has not been tested and there is no reliable reference.

Seal tightly and store in a cool (not exceeding 20°C) dry place.

300,000 units

24 months

Changchun Haiwang Biological Pharmaceutical Co., Ltd.

• Founded in:

  1995-01-25

• Address:

  No. 833, Huoju Road, Qianjin Street, High-tech Development Zone, Changchun City, Jilin Province;

• Tax NO.:

  91220101243880532N

• Registered Funds:

  20 million yuan

• Website:

  Log in to view

• Email:

  Log in to view